Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II StudyJournal of Clinical Oncology, 2009
- Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301Journal of Clinical Oncology, 2009
- Radiologic–pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres #Hepatology, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- Phase II Study of Sorafenib in Patients With Advanced Hepatocellular CarcinomaJournal of Clinical Oncology, 2006
- Radiation therapy for hepatocellular carcinomaCancer, 2006
- Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular CarcinomaJournal of Clinical Oncology, 2005
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancerCancer, 1983